33 related articles for article (PubMed ID: 19181274)
1. Seventy-Five Years of Research on Protein Binding.
Dalhoff A
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158276
[TBL] [Abstract][Full Text] [Related]
2. Correction: Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding.
Fele-Paranj A; Saboury B; Uribe C; Rahmim A
EJNMMI Radiopharm Chem; 2024 Mar; 9(1):22. PubMed ID: 38504056
[No Abstract] [Full Text] [Related]
3. The future of the radiopharmaceutical sciences.
Lapi SE; Scott PJH
Nucl Med Biol; 2024; 132-133():108907. PubMed ID: 38599143
[No Abstract] [Full Text] [Related]
4. Competitive displacement of serum protein binding of radiopharmaceuticals with amino acid infusion investigated with N-isopropyl-p-123I-iodoamphetamine.
Kuga N; Shikano N; Takamura N; Nishii R; Yamasaki K; Kobayashi M; Nagamachi S; Tamura S; Kawai K
J Nucl Med; 2009 Aug; 50(8):1378-83. PubMed ID: 19617322
[TBL] [Abstract][Full Text] [Related]
5. Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humans.
Fuse E; Tanii H; Takai K; Asanome K; Kurata N; Kobayashi H; Kuwabara T; Kobayashi S; Sugiyama Y
Cancer Res; 1999 Mar; 59(5):1054-60. PubMed ID: 10070963
[TBL] [Abstract][Full Text] [Related]
6. N-isopropyl-4-[123I]iodoamphetamine (123I-IMP) products: a difference in radiochemical purity, unmetabolized fraction, and octanol extraction fraction in arterial blood and regional brain uptake in rats.
Kanai Y; Hasegawa S; Kimura Y; Oku N; Ito H; Fukuda H; Hatazawa J
Ann Nucl Med; 2007 Sep; 21(7):387-91. PubMed ID: 17876551
[TBL] [Abstract][Full Text] [Related]
7. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
Soma LR; Uboh CE; Rudy JA; Smith MS
Am J Vet Res; 1996 Apr; 57(4):517-21. PubMed ID: 8712517
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
[TBL] [Abstract][Full Text] [Related]
9. Serum protein binding displacement: theoretical analysis using a hypothetical radiopharmaceutical and experimental analysis with 123I-N-isopropyl-p-iodoamphetamine.
Kawai K; Nishii R; Shikano N; Makino N; Kuga N; Yoshimoto M; Jinnouchi S; Nagamachi S; Tamura S; Takamura N
Nucl Med Biol; 2009 Jan; 36(1):99-106. PubMed ID: 19181274
[TBL] [Abstract][Full Text] [Related]
10. [Study on binding of drug to serum protein].
Otagiri M
Yakugaku Zasshi; 2009 Apr; 129(4):413-25. PubMed ID: 19336995
[TBL] [Abstract][Full Text] [Related]
11. A molecular functional study on the interactions of drugs with plasma proteins.
Otagiri M
Drug Metab Pharmacokinet; 2005 Oct; 20(5):309-23. PubMed ID: 16272748
[TBL] [Abstract][Full Text] [Related]
12. [Interpretations of laboratory test data on serum protein binding].
Takamura N; Tokunaga J; Arimori K
Yakugaku Zasshi; 2007 Feb; 127(2):231-6. PubMed ID: 17268139
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
